We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLPC:NASDAQPreformed Line Products Company Analysis

Data as of 2026-07-16 - not real-time

$328.87

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Preformed Line Products (PLPC) is trading at $328.87, roughly 13% below the consensus 12‑month target of $372, yet its DCF‑derived fair value sits near $88, highlighting a stark valuation disconnect. The stock carries a lofty trailing P/E of 47× versus an industry average of 31× and a price‑to‑book of 3.4×, suggesting it is currently overvalued on traditional metrics. However, the company posted robust revenue growth of 19% YoY, maintains a gross margin of 31% and an operating margin of 7.8%, and its dividend payout is modest at 12% of earnings with a 0.24% yield, indicating dividend sustainability. Technically, the price sits above the 20‑day SMA (369) and 50‑day SMA (365) but below the 200‑day SMA (276), the RSI is at 38 (approaching oversold), MACD is bearish, and volume is trending down, pointing to mixed short‑term momentum while the broader trend remains bullish. Recent news confirmed a quarterly dividend of $0.21 per share and noted a mention on Mad Money, underscoring modest market attention.
Given the high beta (~2.0), 30‑day volatility of nearly 63%, and a max drawdown of 22%, the stock is volatile, but its global footprint across 20 countries and low payout ratio provide a cushion for long‑term investors who can tolerate price swings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near recent support at $316
  • Bearish MACD histogram
  • Decreasing volume indicating waning buying pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 19% and expanding global footprint
  • Target price upside of ~13% to $372
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term demand for utility and communications infrastructure
  • High beta and volatility may erode returns
  • Valuation gap between market price and DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth18.70%
Profit Margin4.92%
P/E Ratio47.3
ROE7.54%
ROA5.53%
Debt/Equity10.47
P/B Ratio3.4
Op. Cash Flow$73.9M
Free Cash Flow$14.6M
Industry P/E30.9

Technical Analysis

TrendBullish
RSI38.8
Support$316.19
Resistance$414.35
MA 20$368.78
MA 50$364.53
MA 200$275.93
MACDBearish
VolumeDecreasing
Fear & Greed Index91.55

Valuation

Fair Value$87.70
Target Price$372.00
Upside/Downside13.11%
GradeOvervalued
TypeGrowth
Dividend Yield0.24%

Risk Assessment

Beta2.00
Volatility62.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.